Novartis, Elsevier collaborate on risk-assessment tool
The two companies plan to work together on the creation a drug-development technology tool that helps in safety margin risk assessment prediction.
The two companies plan to work together on the creation a drug-development technology tool that helps in safety margin risk assessment prediction.
A leader from the AI technology firm discusses how life-sciences pros are harnessing AI to help continue their work in the face of the pandemic.
As the pandemic maintains a grip on the globe, the federal agency continues to offer advice and take action to guide life-sciences professionals.
The clear evidence of increased risk of COVID-19 infection amongst ethnic minority groups, people from Black and Asian backgrounds, is of urgent public health importance, according to the authors of a paper published today by The Lancet.